搜索临床试验以:阿托伐他汀 20 毫克/非诺贝特 160 毫克固定剂量
总计513个结果
-
Organon and CoMerck Shering-Plough JV Study完全的
-
Reata, a wholly owned subsidiary of BiogenAbbVie; Friedreich's Ataxia Research Alliance主动,不招人
-
Merck Sharp & Dohme LLC终止DLBCL | AML,包括新发 AML 和继发于 MDS 的 AML
-
Juventas Therapeutics, Inc.未知
-
Henan Institute of Cardiovascular Epidemiology招聘中
-
Mount Sinai Hospital, CanadaSunnybrook Health Sciences Centre; McMaster Children's Hospital; The Rotunda Hospital招聘中
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
Neopharma Japan Co., Ltd.Parexel撤销
-
Solvay Pharmaceuticals完全的
-
Rockefeller UniversityBrigham and Women's Hospital; Weill Medical College of Cornell University; University of Cologne完全的
-
Bandim Health Project完全的
-
Organon and Co完全的